Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

NCT00001499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Interventions

DRUG: paclitaxel
DRUG: cisplatin
PROCEDURE: chest radiotherapy

Sponsor

National Cancer Institute (NCI)